BIOA vs STE · rev $9.0M vs P/E 25, rev $5.46B
BioAge Labs, Inc (BIOA) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
BIOA currently screens at market cap $697.9M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the BIOA and STE stock pages for the full models.
Not investment advice.